Interleukin-8 and neutrophil markers in colonic mucosa from patients with ulcerative colitis - PubMed (original) (raw)
. 1992 Oct;87(10):1447-52.
Affiliations
- PMID: 1329495
Interleukin-8 and neutrophil markers in colonic mucosa from patients with ulcerative colitis
R S Izzo et al. Am J Gastroenterol. 1992 Oct.
Abstract
In this study, mediators of inflammation were characterized in colonic and terminal ileum mucosa from subjects with ulcerative colitis. We considered the role of two different chemotactic factors (interleukin-8 and leukotriene B4) and of myeloperoxidase in the pathology of inflammatory bowel disease. Serial biopsy specimens were taken at different sites, washed in 0.02 M phosphate/saline buffer, homogenized, and then sonically disrupted. In both the proximal and distal regions of the colonic mucosa of ulcerative colitis patients, there was a more than 10-fold increase in interleukin-8 levels over that in control subjects (> 300 pg/mg protein vs. 30 pg/mg protein in controls, p < or = 0.01). However, terminal ileum levels of interleukin-8 were the same in ulcerative colitis and control groups (150 pg/mg protein). There was also a 3- to 5-fold increase in leukotriene B4 levels and a several-fold increase in myeloperoxidase levels throughout the colonic mucosa in patients with ulcerative colitis. This study demonstrates that 1) interleukin-8 may have an immunoregulatory role in the pathogenesis of inflammatory bowel disease, and 2) interleukin-8, myeloperoxidase, and leukotriene B4 may be useful markers for the biochemical identification of inflammatory bowel disease.
Similar articles
- Enhanced synthesis of leukotriene B4 by colonic mucosa in inflammatory bowel disease.
Sharon P, Stenson WF. Sharon P, et al. Gastroenterology. 1984 Mar;86(3):453-60. Gastroenterology. 1984. PMID: 6319219 - Neutrophil-activating peptide (interleukin-8) in colonic mucosa from patients with Crohn's disease.
Izzo RS, Witkon K, Chen AI, Hadjiyane C, Weinstein MI, Pellecchia C. Izzo RS, et al. Scand J Gastroenterol. 1993 Apr;28(4):296-300. doi: 10.3109/00365529309090244. Scand J Gastroenterol. 1993. PMID: 8387693 - Mucosal factors inducing neutrophil movement in ulcerative colitis: the role of interleukin 8 and leukotriene B4.
Cole AT, Pilkington BJ, McLaughlan J, Smith C, Balsitis M, Hawkey CJ. Cole AT, et al. Gut. 1996 Aug;39(2):248-54. doi: 10.1136/gut.39.2.248. Gut. 1996. PMID: 8977339 Free PMC article. - Interleukin 1 beta (IL-1 beta) release from fresh and cultured colonic mucosa in patients with ulcerative colitis (UC).
Gionchetti P, Campieri M, Belluzzi A, Tampieri M, Bertinelli E, Brignola C, Ferretti M, Boni P, Iannone P, Miglioli M, et al. Gionchetti P, et al. Agents Actions. 1992;Spec No:C50-2. Agents Actions. 1992. PMID: 1442335 Review. - Effect of butyrate enemas on inflammation and antioxidant status in the colonic mucosa of patients with ulcerative colitis in remission.
Hamer HM, Jonkers DM, Vanhoutvin SA, Troost FJ, Rijkers G, de Bruïne A, Bast A, Venema K, Brummer RJ. Hamer HM, et al. Clin Nutr. 2010 Dec;29(6):738-44. doi: 10.1016/j.clnu.2010.04.002. Epub 2010 May 15. Clin Nutr. 2010. PMID: 20471725 Review.
Cited by
- 5-ASA-loaded SiO2 nanoparticles-a novel drug delivery system targeting therapy on ulcerative colitis in mice.
Tang H, Xiang D, Wang F, Mao J, Tan X, Wang Y. Tang H, et al. Mol Med Rep. 2017 Mar;15(3):1117-1122. doi: 10.3892/mmr.2017.6153. Epub 2017 Jan 26. Mol Med Rep. 2017. PMID: 28138699 Free PMC article. - Accumulation, activation, and survival of neutrophils in ulcerative colitis: regulation by locally produced factors in the colon and impact of steroid treatment.
Lampinen M, Sangfelt P, Taha Y, Carlson M. Lampinen M, et al. Int J Colorectal Dis. 2008 Oct;23(10):939-46. doi: 10.1007/s00384-008-0509-x. Epub 2008 Jul 2. Int J Colorectal Dis. 2008. PMID: 18594843 - Anti-inflammatory activity of probiotic Bifidobacterium: enhancement of IL-10 production in peripheral blood mononuclear cells from ulcerative colitis patients and inhibition of IL-8 secretion in HT-29 cells.
Imaoka A, Shima T, Kato K, Mizuno S, Uehara T, Matsumoto S, Setoyama H, Hara T, Umesaki Y. Imaoka A, et al. World J Gastroenterol. 2008 Apr 28;14(16):2511-6. doi: 10.3748/wjg.14.2511. World J Gastroenterol. 2008. PMID: 18442197 Free PMC article. - Leukocyte migration in experimental inflammatory bowel disease.
Van Rees EP, Palmen MJ, Van De Goot FR, Macher BA, Dieleman LA. Van Rees EP, et al. Mediators Inflamm. 1997;6(2):85-93. doi: 10.1080/09629359791776. Mediators Inflamm. 1997. PMID: 18472841 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Other Literature Sources
Medical
Research Materials